Found: 38
Select item for more details and to access through your institution.
European regulatory experience with drugs for central nervous system disorders.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 2, p. 89, doi. 10.1038/nrd4511
- By:
- Publication type:
- Article
Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 395, doi. 10.1038/nrd3713-c1
- By:
- Publication type:
- Article
The risks of risk aversion in drug regulation.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The risks of risk aversion in drug regulation.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 907, doi. 10.1038/nrd4129
- By:
- Publication type:
- Article
An audience with Guido Rasi. Interview by Asher Mullard.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Need for redesigning pharmacologic research in older individuals. A position statement of the Geriatric Working Group of the Agenzia Italiana del Farmaco (AIFA)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Need for Redesigning Pharmacologic Research in Older Individuals. A Position Statement of the Geriatric Working Group of the Agenzia Italiana del Farmaco (AIFA).
- Published in:
- 2011
- By:
- Publication type:
- Letter
Development of a Digital Research Assistant for the Management of Patients' Enrollment in Oncology Clinical Trials within a Research Hospital.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 4, p. 244, doi. 10.3390/jpm11040244
- By:
- Publication type:
- Article
Thymosin {alpha}1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo.
- Published in:
- International Immunology, 2007, v. 19, n. 11, p. 1261, doi. 10.1093/intimm/dxm097
- By:
- Publication type:
- Article
Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats.
- Published in:
- International Journal of Cancer, 1994, v. 57, n. 5, p. 701, doi. 10.1002/ijc.2910570516
- By:
- Publication type:
- Article
Combination therapy with thymosin α.
- Published in:
- International Journal of Cancer, 1992, v. 50, n. 3, p. 493, doi. 10.1002/ijc.2910500327
- By:
- Publication type:
- Article
Stimulatory effect of Eucalyptus essential oil on innate cell-mediated immune response.
- Published in:
- BMC Immunology, 2008, v. 9, p. 1, doi. 10.1186/1471-2172-9-17
- By:
- Publication type:
- Article
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1194, n. 1, p. 6, doi. 10.1111/j.1749-6632.2010.05484.x
- By:
- Publication type:
- Article
Thymosin α1.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1112, p. 326, doi. 10.1196/annals.1415.002
- By:
- Publication type:
- Article
Immunopharmacology of Thymosin α1 and Cytokine Synergy.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1112, p. 235, doi. 10.1196/annals.1415.036
- By:
- Publication type:
- Article
Thymosin Alpha 1.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1112, p. 225, doi. 10.1196/annals.1415.044
- By:
- Publication type:
- Article
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis.
- Published in:
- Hepatology Research, 2014, v. 44, n. 9, p. 1008, doi. 10.1111/hepr.12239
- By:
- Publication type:
- Article
The International Coalition of Medicines Regulatory Authorities (ICMRA).
- Published in:
- WHO Drug Information, 2015, v. 29, n. 1, p. 3
- By:
- Publication type:
- Article
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity.
- Published in:
- Frontiers in Microbiology, 2023, p. 1, doi. 10.3389/fmicb.2023.1155624
- By:
- Publication type:
- Article
How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory-HTA parallel scientific advice.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 4, p. 965, doi. 10.1111/bcp.13023
- By:
- Publication type:
- Article
Fifty years after thalidomide; what role for drug regulators?
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 74, n. 5, p. 731, doi. 10.1111/j.1365-2125.2012.04255.x
- By:
- Publication type:
- Article
A critical evaluation of the process of drug discovery and evaluation: is the current approach the best possible one?
- Published in:
- Annali dell'Istituto Superiore di Sanita, 2011, v. 47, n. 1, p. 1
- By:
- Publication type:
- Article
Steps forward in regulatory pathways for acute and chronic heart failure.
- Published in:
- 2015
- By:
- Publication type:
- journal article
High CD169 Monocyte/Lymphocyte Ratio Reflects Immunophenotype Disruption and Oxygen Need in COVID-19 Patients.
- Published in:
- Pathogens, 2021, v. 10, n. 12, p. 1639, doi. 10.3390/pathogens10121639
- By:
- Publication type:
- Article
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats.
- Published in:
- International Journal of Cancer, 2004, v. 110, n. 1, p. 70, doi. 10.1002/ijc.20063
- By:
- Publication type:
- Article
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells.
- Published in:
- International Journal of Cancer, 2000, v. 85, n. 4, p. 540, doi. 10.1002/(SICI)1097-0215(20000215)85:4<540::AID-IJC16>3.0.CO;2-V
- By:
- Publication type:
- Article
Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 5, p. 1212, doi. 10.1002/cpt.2083
- By:
- Publication type:
- Article
Clinical Trials for COVID‐19: Can we Better Use the Short Window of Opportunity?
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 730, doi. 10.1002/cpt.1891
- By:
- Publication type:
- Article
Big Data – How to Realize the Promise.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 753, doi. 10.1002/cpt.1736
- By:
- Publication type:
- Article
Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 773, doi. 10.1002/cpt.1638
- By:
- Publication type:
- Article
Pharmacovigilance 2030: Invited Commentary for the January 2020 "Futures" Edition of Clinical Pharmacology and Therapeutics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 1, p. 89, doi. 10.1002/cpt.1689
- By:
- Publication type:
- Article
Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 4, p. 912, doi. 10.1002/cpt.1226
- By:
- Publication type:
- Article
Differentiation of human melanoma cells induced by cyanidin-3-O-β-glucopyranoside.
- Published in:
- FASEB Journal, 2004, v. 18, n. 15, p. 1940, doi. 10.1096/fj.04-1925fje
- By:
- Publication type:
- Article
The COVID‐19 crisis as an opportunity to strengthen global regulatory coordination for sustained enhanced access to diagnostics and therapeutics.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 777, doi. 10.1111/cts.12954
- By:
- Publication type:
- Article
Legends of allergy and immunology: Sergio Bonini.
- Published in:
- Allergy, 2021, v. 76, n. 10, p. 3227, doi. 10.1111/all.14847
- By:
- Publication type:
- Article
Preliminary Evidence of the Differential Expression of Human Endogenous Retroviruses in Kawasaki Disease and SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 20, p. 15086, doi. 10.3390/ijms242015086
- By:
- Publication type:
- Article
Open Clinical Trial Data for All? A View from Regulators.
- Published in:
- 2012
- By:
- Publication type:
- Opinion